Amgen just got one step closer to bringing its Ozempic competitor to market Yahoo
Author: admin
Good old pills vie for weight-loss market – Chemical & Engineering News
Good old pills vie for weight-loss market Chemical & Engineering News
This state will provide weight loss medication to Medicaid patients starting in 2026: Will the bill pass? – Marca English
This state will provide weight loss medication to Medicaid patients starting in 2026: Will the bill…
Novo Nordisk cuts Wegovy prices, following Eli Lilly on Zepbound – PBS NewsHour
Novo Nordisk cuts Wegovy prices, following Eli Lilly on Zepbound PBS NewsHour
Novo Nordisk Launches Lower-Cost Wegovy, Following Eli Lilly Into Direct-to-Patient Sales – MedCity News
Novo Nordisk Launches Lower-Cost Wegovy, Following Eli Lilly Into Direct-to-Patient Sales MedCity News
Biosimilars drive Sandoz growth ahead of unclear tariff effects in 2025
Sales in Sandoz’s biosimilar business grew 30% buoyed by US launches including Humira-biosimilar.
Novo Nordisk Joins Legal Battle Over Weight Loss Drug Shortage – Bloomberg Law
Novo Nordisk Joins Legal Battle Over Weight Loss Drug Shortage Bloomberg Law
Jazz Pharmaceuticals bids for Chimerix in $935m deal
The acquisition will give Jazz access to Chimerix’s lead investigational candidate dordaviprone.
Berberine Is Being Called ‘Nature’s Ozempic’—Does It Really Work for Weight Loss? – Verywell Health
Berberine Is Being Called ‘Nature’s Ozempic’—Does It Really Work for Weight Loss? Verywell Health
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly – WJTV
Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly WJTV